dc.contributor | Hospital Universitari de Girona Dr Josep Trueta |
dc.contributor.author | Sanvisens, Arantza |
dc.contributor.author | Puigdemont, Montserrat |
dc.contributor.author | Vidal-Vila, Anna |
dc.contributor.author | Lopez-Bonet, Eugeni |
dc.contributor.author | Martín-Romero, Ferran |
dc.contributor.author | Marcos-Gragera, Rafael |
dc.contributor.author | Rubió-Casadevall, Jordi |
dc.date.accessioned | 2022-02-03T13:14:05Z |
dc.date.available | 2022-02-03T13:14:05Z |
dc.date.issued | 2021-12-16 |
dc.identifier.citation | Sanvisens A, Puigdemont, M, Rubió-Casadevall J, Vidal-Vila A, López-Bonet E, Martín-Romero F, et al. Differences in the Impact of COVID-19 on Pathology Laboratories and Cancer Diagnosis in Girona. Int J Environ Res Public Health. 2021 Dec 16;18(24):13269. |
dc.identifier.issn | 1660-4601 |
dc.identifier.uri | https://hdl.handle.net/11351/6968 |
dc.description | Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Càncer; Diagnòstic; Patologia |
dc.description.sponsorship | This work was partially funded by the Josep Carreras Leukaemia Research Institute (grant number: FIJC1100) and the Agency for Management of University and Research Grants, Government of Catalonia (grant number: 2017SGR00733) |
dc.language.iso | eng |
dc.publisher | MDPI |
dc.relation.ispartofseries | International journal of environmental research and public health;18(24) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | COVID-19 (Malaltia) |
dc.subject | Laboratoris de patologia |
dc.subject | Càncer - Diagnòstic |
dc.subject.mesh | Coronavirus Infections |
dc.subject.mesh | Neoplasms |
dc.subject.mesh | Pathology |
dc.title | Differences in the Impact of COVID-19 on Pathology Laboratories and Cancer Diagnosis in Girona |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3390/ijerph182413269 |
dc.subject.decs | infecciones por Coronavirus |
dc.subject.decs | neoplasias |
dc.subject.decs | anatomía patológica |
dc.relation.publishversion | https://doi.org/10.3390/ijerph182413269 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Sanvisens A] Epidemiology Unit and Girona Cancer Registry, Institut de Recerca Contra la Leucèmia Josep Carreras, Girona, Spain. [Puigdemont M, Vidal-Vila, A] Epidemiology Unit and Girona Cancer Registry, Institut Català d'Oncologia, Pla Director d'Oncologia, Girona, Spain. Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI), Girona, Spain. [Rubió-Casadevall J] Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI), Girona, Spain. Medical Oncology Department, Institut Català d'Oncologia, Hospital Universitari Dr. Josep Trueta, Girona, Spain. School of Medicine, Universitat de Girona, Girona, Spain. [López-Bonet E] Department d’Anatomia Patològica Hospital Universitari de Girona Dr. Josep Trueta, Institut Català de la Salut (ICS), Girona, Spain [Martín-Romero F] Department of Pathology, Hospital de Figueres, Fundació Salut Empordà, Figueres, Spain. [Marcos-Gragera, R] ]Epidemiology Unit and Girona Cancer Registry, Institut de Recerca Contra la Leucèmia Josep Carreras, Girona, Spain. Epidemiology Unit and Girona Cancer Registry, Institut Català d'Oncologia, Pla Director d'Oncologia, Girona, Spain. Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI), Girona, Spain. School of Medicine, Universitat de Girona, Girona, Spain |
dc.identifier.pmid | 34948878 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |